[
  {
    "ts": "2025-12-30T04:59:50+00:00",
    "headline": "Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ:GILD) announced on December 22 that it has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, which include long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. Management reported […]",
    "url": "https://finance.yahoo.com/news/gilead-sciences-gild-affordable-healthcare-045950097.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e0933a00-3f9e-3eb3-a779-9a03442f2f40",
      "content": {
        "id": "e0933a00-3f9e-3eb3-a779-9a03442f2f40",
        "contentType": "STORY",
        "title": "Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ:GILD) announced on December 22 that it has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, which include long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. Management reported […]",
        "pubDate": "2025-12-30T04:59:50Z",
        "displayTime": "2025-12-30T04:59:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Gilead Sciences (GILD) Deserves Attention in the Cheap Quarterly Dividend Stocks Category",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ha22PhpGlsEhK3tmOzGDVw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CkBvnQJGKRIUyIDAWZszGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-affordable-healthcare-045950097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-affordable-healthcare-045950097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]